Work

Tucatinib with capecitabine and trastuzumab in advanced HER2-positive metastatic breast cancer with and without brain metastases: a non-randomised, open-label, phase 1b study

Year: 2018

Type: article

Study design: Clinical Trial

Source: The Lancet Oncology

DOI: 10.1016/s1470-2045(18)30256-0

Authors: Rashmi Murthy, Virginia F Borges, Alison Conlin, Jorge Chaves, Marc Chamberlain, Todd Gray, Alex Vo, Erika Hamilton

Institutions: The University of Texas MD Anderson Cancer Center, University of Colorado Cancer Center, Providence Portland Medical Center, Northwest Medical Specialties, Sarah Cannon

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: European Society for Medical Oncology, National Institutes of Health

OpenAlex ID: W2803163286

FWCI: 9.684

Cites: 29

Cited by: 171

Related to: 10